Ramya Muddasani

Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial

Nazlı Dizman, Luís Meza, Paulo Gustavo Bergerot et al. · Nature Medicine · 2022 · 473 citations · Full text

Life Sciences, Oncology, Pharmacology +17

Evidence of a role for the novel zinc-finger transcription factor ZKSCAN3 in modulating Cyclin D2 expression in multiple myeloma

Lin Yang, H. Wang, Steven M. Kornblau et al. · Oncogene · 2010 · 63 citations

Medicine, Cell Biology, Molecular Genetics +13

The miR-184 Binding-Site rs8126 T>C Polymorphism in TNFAIP2 Is Associated with Risk of Gastric Cancer

Yu Xu, Hongxia Ma, Hongping Yu et al. · PLoS ONE · 2013 · 42 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Plasma Cell Enrichment Enhances Detection of High-Risk Cytogenomic Abnormalities by Fluorescence In Situ Hybridization and Improves Risk Stratification of Patients With Plasma Cell Neoplasms

Gary Lu, Ramya Muddasani, Robert Z. Orlowski et al. · Archives of Pathology & Laboratory Medicine · 2013 · 34 citations

Medicine, Hematology, Pathology +16

Complementary Role of Circulating Tumor DNA Assessment and Tissue Genomic Profiling in Metastatic Renal Cell Carcinoma

Zeynep Büşra Zengin, Caroline Weipert, Nicholas Salgia et al. · Clinical Cancer Research · 2021 · 27 citations · Full text

Medicine, Molecular Genetics, Oncology +17